Candeblo plus HCT 8 mg/12,5 mg - Tabletten New
Recall
|
Medicines
|
25/06/2026
The marketing authorisation holder informed its customers on June 25, 2026, that several reports from users have been received indicating that tablets from the affected batches crumble already during removal from the blister. This defect occurs prior to administration and may impair the proper removal from the packaging as well as the intended use of the medicinal product. For this reason, the affected batches are being recalled.
| Name of the medicinal product | Candeblo plus HCT 8 mg/12,5 mg - Tabletten |
|---|---|
| Marketing authorisation number(s) | 1-31624 |
| CIP code | 3918141 |
| Marketing authorisation holder | G.L. Pharma GmbH |
| Batch number(s) | K07273 Physician sample: G08226 |
| Expiry date | 06/30/2027 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-5737 |
Further inquiry note
Page last modified:
25/06/2026